Navigation Links
HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
Date:6/17/2013

gned to confirm observations from ENDURANCE that sites adhering to more regular monitoring and management of patient blood pressure witnessed a notably lower incidence of neurological events.  

In this supplemental cohort, HeartWare will enroll up to an additional 240 HeartWare HVAD patients, as well as up to an additional 120 control patients using a randomization scheme consistent with the ENDURANCE protocol.  Patients will be followed for 12 months after implant.  HeartWare intends to incorporate the data from this new cohort into an anticipated Pre-Market Approval (PMA) Application seeking approval of the HeartWare System for the Destination Therapy indication.  

Patient enrollment in this supplemental cohort can commence at the 50 centers participating in the ENDURANCE clinical trial, following edits to the protocol as prescribed by FDA and Institutional Review Board approvals at each of the centers.

On November 20, 2012, FDA granted approval of the HeartWare System for the Bridge-to-Transplant indication.  Concurrent with approval, the Company commenced a post-approval study (PAS) to assess device performance in a real-world setting.  HeartWare's PAS is a registry consisting of 600 patients who receive an HVAD and an additional 600 control patients derived from a contemporaneous group of continuous flow, intra-corporeal LVAD patients entered into the INTERMACS database.  HeartWare expects enrollment for both arms of the PAS will be complete by year's end. 

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally requir
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
2. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
3. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
4. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
5. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
6. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
7. HeartWare Schedules First Quarter Conference Call And Webcast
8. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
9. HeartWare International, Inc. Announces Public Offering of Common Stock
10. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
11. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Serco Inc., a ... the Company has been awarded a re-compete contract ... (NEMSCOM) and its Deployable Medical Systems.  Serco will ... personnel to provide world-class healthcare to meet warfighter ... across the globe. The five year contract has ...
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... supply of medical oxygen is vital to any healthcare ... innovations that not only improve the efficiency of its ... Products will highlight these systems—including systems for emergency ... oxygen loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, in ... of LEGENDplex™ Data Analysis Software, an OEM software ... cytometers.  BioLegend develops and offers varieties of bead-based ... With the support of VigeneTech,s data analysis software, ... analyzed and easily reported LEGENDplex™ ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... Nov. 15, 2011 On November 14, 2011, DHS ... will enter into preliminary talks with Radient Pharmaceuticals Corporation ... both parties.  However, that press release was issued without ... any further discussions, or enter into any business opportunities ...
... ICU Medical, Inc. (NASDAQ: ICUI ) today ... Novation for its full line of Critical Care products, ... in-line blood sampling systems. Effective January 1, 2012, the ... take advantage of special pricing and terms pre-negotiated by ...
Cached Medicine Technology:Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation 2Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products 2
(Date:7/28/2014)... (PRWEB) July 28, 2014 With California ... it is welcome news that a fire blanket ... current protection is under development by SunSeeker Enterprises, Inc. ... to protect spacecraft from the extreme heat of re-entry ... both firefighters and homes. , “Our firefighters routinely lay ...
(Date:7/28/2014)... At some point in their lives, almost everyone will be ... authorities. Distinguishing the circumstances where this is proper is ... every dangerous situation is going to be as blatant as ... a bank get held up. Many dangerous predicaments are ... than they otherwise should. , The Law Offices of Christopher ...
(Date:7/28/2014)... Windsor, Co (PRWEB) July 28, 2014 ... Colorado has unveiled new plans to raise investment capital ... growing 24/7 fitness concept in the United States. , ... increasing popularity of 24/7 fitness centers provide a great ... into this rapidly expanding space. In addition to this, ...
(Date:7/28/2014)... 28, 2014 The report “Industrial ... (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), ... 2018” defines and segments the global industrial enzymes ... value for industrial enzymes. It also identifies driving ... market with analysis of trends, opportunities, burning issues, ...
(Date:7/28/2014)... Medicine (BUSM) report variants in a new gene, PLXNA4, ... (AD). The discovery of this novel genetic association may ... specifically. These findings appear in the Annals of ... dementia affecting 5.4 million Americans including 13 percent of ... percent of people age 85 and older. Genetic factors ...
Breaking Medicine News(10 mins):Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Take Action To Protect Your Fellow Citizens 2Health News:Take Action To Protect Your Fellow Citizens 3Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:Researchers identify potential biomarker for AD 2
... provider offers real estate community ... harmful vapor intrusion, MILFORD, Conn., April 28 ... provider of environmental risk information,services and solutions, today ... level of awareness of the health, investment and ...
... Company,s Military Logistics and Health Care ... Service ... LMT ) has entered into a definitive agreement to acquire,Atlanta, Georgia ... and healthcare services to the,U.S. Department of Defense., As part ...
... raising complication risks, study finds, , , MONDAY, April 28 (HealthDay ... type 1 or type 2 diabetes has doubled since 1999, ... research finds. , In some age groups, the results were ... of teenagers who had diabetes before birth jumped fivefold. ...
... attend day care or play groups have about a ... of childhood leukaemia than those who do not, according ... , The new research, to be presented Tuesday ... of Childhood Leukaemia Conference in London, is the first ...
... President and Chief,Analyst Terence Pitre, Ph.D. Pitre Equity ... based in Minneapolis, Minnesota. Dr. Pitre,said that because ... academia, truth,independence and objectivity will always form the ... is to incorporate,fundamentally sound financial analysis that also ...
... leading provider of,Business Process Outsourcing solutions for ... and exhibiting at two upcoming healthcare,conferences. As ... mid-sized,health plans nationwide, Adaptis actively supports organizations ... with high-impact strategies for,improving member services while ...
Cached Medicine News:Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 2Health News:EDR Poll Finds Environmental Professionals, Property Buyers and Lenders Eager to Apply New Vapor Intrusion Standard During Real Estate Transactions to Protect Health and Investments 3Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 2Health News:Lockheed Martin Agrees to Acquire Eagle Group International, LLC 3Health News:Pre-Pregnancy Diabetes Rates Have Doubled 2Health News:Pre-Pregnancy Diabetes Rates Have Doubled 3Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:New Independent Research Firm Targets Firms with Little or No Analyst Following 2Health News:Adaptis Sponsors Two Upcoming Healthcare Conferences 2
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... an immunochromatography based one step in vitro ... Opiates and its metabolite in human urine,specimens. ... above a cut-off level of 300 ng/mL,can ... evaluated in the point of care location ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: